Literature DB >> 22399423

Inherited mitochondrial disorders.

Josef Finsterer1.   

Abstract

Though inherited mitochondrial disorders (MIDs) are most well known for their syndromic forms, for which widely known acronyms (MELAS, MERRF, NARP, LHON etc.) have been coined, the vast majority of inherited MIDs presents in a non-syndromic form. Since MIDs are most frequently multisystem disorders already at onset or during the disease course, a MID should be suspected if there is a combination of neurological and non-neurological abnormalities. Neurological abnormalities occurring as a part of a MID include stroke-like episodes, epilepsy, migraine-like headache, movement disorders, cerebellar ataxia, visual impairment, encephalopathy, cognitive impairment, dementia, psychosis, hypopituitarism, aneurysms, or peripheral nervous system disease, such as myopathy, neuropathy, or neuronopathy. Non-neurological manifestations concern the ears, the endocrine organs, the heart, the gastrointestinal tract, the kidneys, the bone marrow, and the skin. Whenever there is an unexplained combination of neurological and non-neurological disease in a patient or kindred, a MID should be suspected and appropriate diagnostic measures initiated. Genetic testing should be guided by the phenotype, the biopsy findings, and the biochemical results.

Entities:  

Mesh:

Year:  2012        PMID: 22399423     DOI: 10.1007/978-94-007-2869-1_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

1.  Secondary manifestations of mitochondrial disorders.

Authors:  Josef Finsterer
Journal:  J Zhejiang Univ Sci B       Date:  2020-07       Impact factor: 3.066

Review 2.  Polycystic ovary syndrome in mitochondrial disorders due mtDNA or nDNA variants.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

3.  Migraine genetics: current findings and future lines of research.

Authors:  A M Persico; M Verdecchia; V Pinzone; V Guidetti
Journal:  Neurogenetics       Date:  2014-12-14       Impact factor: 2.660

Review 4.  A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development.

Authors:  Ahmad M Aldossary; Chinedu S M Ekweremadu; Ifunanya M Offe; Haya A Alfassam; Sooyeon Han; Vivian C Onyali; Chukwuebuka H Ozoude; Emmanuel A Ayeni; Chinekwu S Nwagwu; Abdulrahman A Halwani; Nada H Almozain; Essam A Tawfik
Journal:  Saudi Pharm J       Date:  2022-03-15       Impact factor: 4.562

5.  Renal manifestations of primary mitochondrial disorders.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza
Journal:  Biomed Rep       Date:  2017-04-12

6.  Haematological abnormalities in mitochondrial disorders.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Singapore Med J       Date:  2015-07       Impact factor: 1.858

7.  mtDNA T8993G mutation-induced F1F0-ATP synthase defect augments mitochondrial dysfunction associated with hypoxia/reoxygenation: the protective role of melatonin.

Authors:  Wen-Yi Huang; Mei-Jie Jou; Tsung-I Peng; I Peng Tsung
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

8.  Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells.

Authors:  Nicole Min Qian Pek; Qian Hua Phua; Beatrice Xuan Ho; Jeremy Kah Sheng Pang; Jin-Hui Hor; Omer An; Henry He Yang; Yang Yu; Yong Fan; Shi-Yan Ng; Boon-Seng Soh
Journal:  Cell Death Dis       Date:  2019-10-22       Impact factor: 8.469

Review 9.  Role of the mtDNA Mutations and Mitophagy in Inflammaging.

Authors:  Siarhei A Dabravolski; Nikita G Nikiforov; Alexander D Zhuravlev; Nikolay A Orekhov; Andrey V Grechko; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

Review 10.  Headache attributed to cranial or cervical vascular disorders.

Authors:  Siddharth Kapoor
Journal:  Curr Pain Headache Rep       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.